ANBIO BIOTECHNOLOGY LTD
NNNN · NASDAQ
更新于 2026-10-13 14:43:15
$4.29-2.72%
- 今日最高
- $4.44
- 今日最低
- $4.27
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $4.61
- 昨日收盘价
- $4.41
- 成交量
- 2.48万
- 市值
- $6.34亿
- 本益比（P/E）
- 62.20X
- 每股收益（EPS）
- $0.23
昨日价格区间
$4.41$4.67
52周价格区间
$4.15$44.73
公司概况
- 板块
- 医疗保健
- 行业
- 生物技术
- 子行业
- 医疗器械与用品
- 总部
- FRIEDRICH-EBERT-ANLAGE 35-37, FRANKFURT AM MAIN, GERMANY, 60327
- 国家
- 德国
- 上市日期
- 2025-02-19
- 财年截止
- 十二月
- 流通股数
- 4389万
- CIK
- 0001982708
Anbio Biotechnology 在欧盟、亚太、北美、南美、非洲及全球范围内提供体外诊断 (IVD) 产品。公司总部位于德国法兰克福。
财务指标
营业收入
2026-03-31
$473.75万
2025-09-30
$203.11万
2025-06-30
$500.72万
2024-12-31
$252.82万
营业支出
2026-03-31
$106.12万
2025-09-30
$45.49万
2025-06-30
$94.52万
2024-12-31
$387.29万
净利润
2026-03-31
$303.87万
2025-09-30
$130.27万
2025-06-30
$414.8万
2024-12-31
-$132.47万
净利润率
2026-03-31
64.14%
2025-09-30
64.14%
2025-06-30
82.83%
2024-12-31
-52.39%
每股收益
2026-03-31
--
2025-09-30
$0.09
2025-06-30
--
2024-12-31
--
息税折旧摊销前利润
2026-03-31
$279.95万
2025-09-30
--
2025-06-30
$367.76万
2024-12-31
-$132.47万
有效税率
2026-03-31
--
2025-09-30
--
2025-06-30
--
2024-12-31
--
| 项目 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|---|
| 营业收入 | $473.75万 | $203.11万 | $500.72万 | $252.82万 |
| 营业支出 | $106.12万 | $45.49万 | $94.52万 | $387.29万 |
| 净利润 | $303.87万 | $130.27万 | $414.8万 | -$132.47万 |
| 净利润率 | 64.14% | 64.14% | 82.83% | -52.39% |
| 每股收益 | -- | $0.09 | -- | -- |
| 息税折旧摊销前利润 | $279.95万 | -- | $367.76万 | -$132.47万 |
| 有效税率 | -- | -- | -- | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。